Amarin Corp Plcuk (AMRN) Assets Average (2011 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Assets Average of $658.3 million for Q1 2026, down 1.83% YoY from $670.5 million in Q1 2025, and down 1.06% sequentially from $665.3 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Assets Average (2011 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Assets Average across 16 years of filings, most recently posting $658.3 million for Q1 2026.

  • In Q1 2026, Assets Average fell 1.83% year-over-year to $658.3 million; the TTM figure through Mar 2026 stood at $658.3 million (down 1.83% YoY), while the FY2025 annual figure was $678.1 million, down 10.61% from the prior year.
  • Assets Average fell to $658.3 million in Q1 2026, from $665.3 million in the prior quarter.
  • Over the last five years, Assets Average for AMRN reached as high as $1.0 billion in Q1 2022 and fell as low as $658.3 million in Q1 2026.
  • The 5-year median for Assets Average is $810.8 million (2024), against an average of $804.2 million.
  • Annual changes were most pronounced in 2022 — Assets Average advanced 4.37% — and 2025, when it retreated 17.31%.
  • A 5-year view of Assets Average shows it stood at $897.2 million in 2022, then fell by 6.9% to $835.4 million in 2023, then dropped by 14.05% to $718.0 million in 2024, then fell by 7.34% to $665.3 million in 2025, then decreased by 1.06% to $658.3 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $658.3 million, $665.3 million, and $665.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 114.53 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 200.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 135.21 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 114.04 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 132.78 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 91.55 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 57.65 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 208.08 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 658.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 658.27 Mn
Dec 31, 2025 665.29 Mn
Sep 30, 2025 664.97 Mn
Jun 30, 2025 662.91 Mn
Mar 31, 2025 670.52 Mn
Dec 31, 2024 717.98 Mn
Sep 30, 2024 775.26 Mn
Jun 30, 2024 794.96 Mn
Mar 31, 2024 810.85 Mn
Dec 31, 2023 835.36 Mn
Sep 30, 2023 849.52 Mn
Jun 30, 2023 860.10 Mn
Mar 31, 2023 873.18 Mn
Dec 31, 2022 897.24 Mn
Sep 30, 2022 940.77 Mn
Jun 30, 2022 973.47 Mn
Mar 31, 2022 1.02 Bn
Dec 31, 2021 1.05 Bn
Sep 30, 2021 1.04 Bn
Jun 30, 2021 1.02 Bn